openPR Logo
Press release

Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Market Value Share, Supply Demand, share and Value Chain 2016-2026

01-31-2018 12:39 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Market

Lymphoma is the most common type of blood cancer that affects that develops in the lymphatic system. Lymphoma are of two major types: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Lymphoma is caused when lymphocytes, type of white blood cells of the immune system grow and multiply uncontrollably. Cancerous lymphocytes may travel to different parts of the body, including the spleen, blood, lymph nodes, bone marrow, and form a mass called a tumor. The two type of lymphocytes that can develop into lymphoma – B-lymphocytes (B-cells) and T-lymphocytes (T-cells). Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma and a common subtype of T-cell lymphoma. ALCL consists of only 2% of NHLs and approx. 20% of T-cell lymphomas. ALCL symptoms includes fever, painless swelling of lymph nodes, weight loss, tiredness, backache and excessive night sweats. It is comprised of two sub-types, based on the expression of a protein called anaplastic lymphoma kinase (ALK): ALK positive and ALK negative ALCL

According to National Cancer Institute, in the 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States and 595,690 people will die from the disease. NHL is the sixth most commonly diagnosed cancer in both men and women in the US. In 2015, it is estimated that there will be 71,850 new cases of NHL (39,850 men and 32,000 women) and 19,790 deaths from NHL. According to GLOBOCAN 2012 estimates the incidence and mortality rate of NHL is 2.7% and 2.4% respectively.

Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1655

Following drugs are being tested for ALCL:

Alisertib (MLN8237)

Bortezomib (Velcade)

Combination of brentuximab vedotin and chemotherapy

Crizotinib (Xalkori)

The global ALCL therapeutics market is segmented on the basis of route of administration, therapeutic areas and region

Segmentation based on Disease Type

Primary ALCL

Relapsed ALCL

Segmentation based on Treatment Type

Chemotherapy

(CHOP) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Brentuximab vedotin

Pralatrexate

Surgery

Radiation therapy

Stem cell transplant

With the increasing geriatric population and rate of diagnosis will boost the overall market for ALCL therapeutics. Moreover, significant increase in the healthcare spending will boost the ALCL therapeutics market during the forecast period.

Request For Table Of Content @ https://www.futuremarketinsights.com/toc/rep-gb-1655

Geographically the ALCL therapeutics market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and MEA region. The areas with the highest incidence of NHL are North America, Europe, and Australasia, as well as several countries in Africa and South America. Also, more than 60% of the world’s new cancer cases occur in Africa, Asia, and Central and South America; 70% of the world’s cancer deaths occur in these regions.

The ALCL can appear on body parts such as skin, organs and other part of the body, they grow slowly and are present on body for longer duration before diagnosis. ALCL that appears on skin is known as primary cutaneous ALCL. Most common types of side effects observed are skin redness and skin irritation is caused. It is being observed that 10 percent primary cutaneous ALCL extends beyond the skin to organ or lymph. Systemic ALCL is parted depending on abnormal form of a protein on their surface called ALK or do not have abnormal form of a protein. These are fast growing and the disease condition in ALK-positive (with abnormal protein) is different from ALK-negative (without abnormal protein). ALK-positive ALCL patients are treated with chemotherapy treatments, patients initially respond to the treatment but relapse within five years, these are found in children’s as well as adults. ALK-negative ALCL patients are treated with stem cell transplantation after remission, these are mostly found in patients above 55 years.

Some major companies in the ALCL therapeutics market are Pfizer, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Seattle Genetics, Inc., Sareum Holdings PLC, Merck Sharp & Dohme Corp., Celgene Corporation and Valeant Pharmaceuticals North America LLC.

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Market Value Share, Supply Demand, share and Value Chain 2016-2026 here

News-ID: 924583 • Views: 110

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for ALCL

Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Market Segments and Key Trend …
Lymphoma is the most common type of blood cancer that affects that develops in the lymphatic system. Lymphoma are of two major types: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Lymphoma is caused when lymphocytes, type of white blood cells of the immune system grow and multiply uncontrollably. Cancerous lymphocytes may travel to different parts of the body, including the spleen, blood, lymph nodes, bone marrow, and form a mass called
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Market to Gain a Stronghold b …
Lymphoma is the most common type of blood cancer that affects that develops in the lymphatic system. Lymphoma are of two major types: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Lymphoma is caused when lymphocytes, type of white blood cells of the immune system grow and multiply uncontrollably. Cancerous lymphocytes may travel to different parts of the body, including the spleen, blood, lymph nodes, bone marrow, and form a mass called
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Market Size will Observe Lucr …
Lymphoma is the most common type of blood cancer that affects that develops in the lymphatic system. Lymphoma are of two major types: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Lymphoma is caused when lymphocytes, type of white blood cells of the immune system grow and multiply uncontrollably. Cancerous lymphocytes may travel to different parts of the body, including the spleen, blood, lymph nodes, bone marrow, and form a mass called
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Market to receive overwhelmin …
Lymphoma is the most common type of blood cancer that affects that develops in the lymphatic system. Lymphoma are of two major types: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Lymphoma is caused when lymphocytes, type of white blood cells of the immune system grow and multiply uncontrollably. Cancerous lymphocytes may travel to different parts of the body, including the spleen, blood, lymph nodes, bone marrow, and form a mass called
New Report Shares Details about the Anaplastic Large Cell Lymphoma (ALCL) Therap …
Lymphoma is the most common type of blood cancer that affects that develops in the lymphatic system. Lymphoma are of two major types: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Lymphoma is caused when lymphocytes, type of white blood cells of the immune system grow and multiply uncontrollably. Cancerous lymphocytes may travel to different parts of the body, including the spleen, blood, lymph nodes, bone marrow, and form a mass called
Global Anaplastic Large Cell Lymphoma (ALCL) Clinical Trials Industry Analysis a …
Market Research Hub's clinical trial report, Global Anaplastic Large Cell Lymphoma (ALCL) Clinical Trials Review, H1, 2017, provides an overview of Anaplastic Large Cell Lymphoma (ALCL) clinical trials scenario. This report provides top line data relating to the clinical trials on Anaplastic Large Cell Lymphoma (ALCL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Request Free Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1068380 Report offers coverage